Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting learning session on bridging the gap between AMR surveillance and antibiotic policy for appropriate therapy.
In this webinar, a panel discussion would take place involving Dr Subramanian Swaminathan as the primary speaker and involving other panelists to participate and discuss the important facts associated with antibiotic resistance and the policies to be adapted for introducing an appropriate therapy.
Antimicrobial surveillance is an essential pillar in fighting against antimicrobial resistance (AMR). There is a lack of understanding and practical guidance on how surveillance data should be linked to AMS activities. Moreover, it becomes much more complex in the hospital setting because of the structural heterogeneity of hospital facilities and services.
Therefore, the webinar will give you an overall guidance on bridging the gap between AMR surveillance and antibiotic policy for appropriate therapy. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions
See More Webinars @ Hidoc Webinars
1.
The main subject is associated with suicide in the United States.
2.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
3.
How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs
4.
Researchers Challenge USPSTF's Lung Cancer Screening Criteria
5.
LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization
1.
Unlocking the Potential of Elotuzumab: A Promising New Cancer Treatment
2.
From Bruises to Blood Clots: Everything You Need to Know about Hematoma
3.
The Digital Biopsy: How Artificial Intelligence is Redefining Cancer Pathology?
4.
Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial
5.
Understanding the HAS-BLED Score: What It Is and Why It Matters
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part X
5.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation